MBX Biosciences Inc Sustainability Reports
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for endocrine and metabolic disorders. The company utilizes its proprietary Precision Endocrine Peptide (PEP) platform to create optimized long-acting product candidates.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00W7W53N4
1 reports from 2024 to 2024
Company Profile
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for endocrine and metabolic disorders. The company utilizes its proprietary Precision Endocrine Peptide (PEP) platform to create optimized long-acting product candidates.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
